ArticleOncology letters2026

Schisandrin B suppresses cholangiocarcinoma by targeting the ROS/p38 MAPK/NF-κB axis.

Junhao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.